Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Correction to: HTX-011 reduced pain intensity and opioid consumption versus bupivacaine HCl in herniorrhaphy: results from the phase 3 EPOCH 2 study

Correction to: Hernia (2019) 23:1071–1080 https://doi.org/10.1007/s10029-019-02023-6

In Abstract, under the section “Results”, the first and third p values are incorrect. The correct p values should be p = 0.0004 and p < 0.0001 respectively.

In Results, under the section “Efficacy” and sub-section “Primary and secondary endpoints”, the p value in the first sentence of the second paragraph is incorrect. The correct p value should be p = 0.0004.

Author information

Correspondence to E. Viscusi.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Viscusi, E., Minkowitz, H., Winkle, P. et al. Correction to: HTX-011 reduced pain intensity and opioid consumption versus bupivacaine HCl in herniorrhaphy: results from the phase 3 EPOCH 2 study. Hernia (2020). https://doi.org/10.1007/s10029-020-02134-5

Download citation